NFATC2 and sarcoma: We showed that mRNA capture sequencing has a higher sensitivity than FISH by the detection of a known pathognomonic fusion in six FISH-negative sarcoma cases and confirmed the presence of four secondary fusion transcripts in EWSR1-NFATC2-positive patients.